Intra-Cellular Therapies
ITCI
#2196
Rank
$6.74 B
Marketcap
$69.72
Share price
3.55%
Change (1 day)
45.61%
Change (1 year)

Revenue for Intra-Cellular Therapies (ITCI)

Revenue in 2023 (TTM): $0.46 B

According to Intra-Cellular Therapies's latest financial reports the company's current revenue (TTM) is $0.46 B. In 2022 the company made a revenue of $0.24 B an increase over the years 2021 revenue that were of $81.7 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intra-Cellular Therapies from 2014 to 2023

Annual revenue

Year Revenue Change
2023 (TTM)$0.46 B85.51%
2022$0.24 B204.91%
2021$81.7 M262.65%
2020$22.53 M37071.49%
2019$0.06 M
2018N/A
2017N/A
2016N/A-100%
2015$0.03 M-94.4%
2014$0.54 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
$0.16 B-63.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$1 M-99.78%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.02 M-97.83%๐Ÿ‡บ๐Ÿ‡ธ USA